Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic × obinutuzumab × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22 Lymphoma, Non-Hodgkin 10 Lymphoma, Follicular 8 Lymphoma 7 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia, Hairy Cell 2 Leukemia 2 Burkitt Lymphoma 2 Neoplasm, Residual 1 Lymphatic Diseases 1 Leukemia, B-Cell 1 Heart Failure 1 Extensive Stage Small Cell Lung Cancer 1 Dendritic Cell Sarcoma, Interdigitating 1 Cytokine Release Syndrome 1

Interventions

fludarabine 3 Whole-Body Irradiation 3 Cyclophosphamide 3 fludarabine phosphate 2 Mycophenolic Acid 2 Cyclosporine 2 treosulfan 1 acalabrutinib 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Stem Cell Transplantation 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Granulocyte Colony-Stimulating Factor 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Filgrastim 1 Dasatinib 1 Cyclosporins 1 Busulfan 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡